Premium
BIANCA: A PHASE 2 STUDY OF THE SAFETY AND EFFICACY OF TISAGENLECLEUCEL IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY MATURE B‐CELL NON‐HODGKIN LYMPHOMA
Author(s) -
MinardColin V.,
Burkhardt B.,
Maude S.,
Phillips C.,
Diaz de Heredia Rubio C.,
Laetsch T.W.,
Curran K.,
Newsome S.,
Murray N.,
Pacaud L.,
Buechner J.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.5_2632
Subject(s) - medicine , lymphoma , oncology , salvage therapy , lymphoblastic lymphoma , refractory (planetary science) , follicular lymphoma , clinical trial , chemotherapy , immunology , t cell , immune system , physics , astrobiology